Biology:Optaflu
From HandWiki
| Influenza (Flu) |
|---|
 |
Optaflu is a cell culture derived influenza vaccine manufactured by Novartis.
History
On April 27, 2007 Novartis received a positive opinion supporting European Union approval of Optaflu. It is the first influenza vaccine made in a mammalian cell line, rather than chicken eggs.[1] The vaccine will be manufactured in Holly Springs, North Carolina. The United States government is providing $500 million in construction costs and guaranteed vaccine purchases.[2]
References
- ↑ "Optaflu, the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval". Novartis. http://www.novartis-vaccines.com/press-room/news/20070427_Optaflu.shtml. Retrieved 2009-04-29.
- ↑ Pollack, Andrew (2009). "Swine Flu Vaccine May Be Months Away, Experts Say". New York Times. https://www.nytimes.com/2009/04/29/business/economy/29vaccine.html?ref=health. Retrieved 2009-04-29. "But Novartis is building a cell culture flu vaccine factory in Holly Springs, N.C., which might be ready for use in 2010 or 2011. The federal government is providing nearly $500 million in construction costs and guaranteed vaccine purchases."
 |
